Skip to main content

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

MTNB holding history

Matinas BioPharma Holdings, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MTNB overviewAll 13F holders of MTNBFull Q4 2025 holdings

Shares (Q4 2025)
59,725
Value
$35.0K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of MTNB by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 202559,725$35.0K<0.1%00.0%UnchangedHolders
Q3 202559,725$112.9K<0.1%00.0%UnchangedHolders
Q2 202559,725$53.2K<0.1%00.0%UnchangedHolders
Q1 202559,725$31.1K<0.1%−46,769−43.9%ReducedHolders
Q4 2024106,494$54.3K<0.1%−79,863−42.9%ReducedHolders
Q3 2024186,357$659.7K<0.1%00.0%UnchangedConverted for a 1-for-50 splitHolders
Q2 20249,317,838$1.48M<0.1%00.0%UnchangedHolders
Q1 20249,317,838$2.53M<0.1%00.0%UnchangedHolders
Q4 20239,317,838$2.01M<0.1%+564,020+6.4%AddedHolders
Q3 20238,753,818$1.14M<0.1%+33,400+0.4%AddedHolders
Q2 20238,720,418$3.14M<0.1%−39,742−0.5%ReducedHolders
Q1 20238,760,160$4.12M<0.1%+153,639+1.8%AddedHolders
Q4 20228,606,521$4.30M<0.1%+176,347+2.1%AddedHolders
Q3 20228,430,174$5.36M<0.1%+16,100+0.2%AddedHolders
Q2 20228,414,074$6.65M<0.1%+529,155+6.7%AddedHolders
Q1 20227,884,919$6.34M<0.1%−47,596−0.6%ReducedHolders
Q4 20217,932,515$8.01M<0.1%+51,414+0.7%AddedHolders
Q3 20217,881,101$10.2M<0.1%+8,638+0.1%AddedHolders
Q2 20217,872,463$6.10M<0.1%+20,613+0.3%AddedHolders
Q1 20217,851,850$8.24M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.